Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Stomach Cancer
 More »

  • Biosimilars: 10 Drugs to Watch
    ... and adjuvant breast cancer, for aggressive HER positive metastatic stomach or gastroesophageal junction cancer. 2012 sales: $6.317 billion (CHF 5.889 billion) (Roche) 2 Patent ...
    4-22-2013
  • Epigenetics Opens New Avenues for DNA Research
    ... field for cancerization was visualized after exposure to various carcinogens, and was reported for multiple malignant tumors, including stomach, breast, liver, and colon cancer. ...
    4-1-2013
  • A "Very Good Year" for Roche
    sales of Herceptin for HER2-positive breast and stomach cancers climbed 11% to about CHF 5.9 billion ($6.4 billion). Cancer drug Avastin was the company's third-best-selling ...
    1-30-2013
  • ATCC Aims to Be More Than a Biorepository
    ... ATCC's expanded Tumor Cell Panels include tissue types with diverse genetic mutations such as bone cancer, leukemia, head and neck cancer, and stomach cancer panels. Cells in these ...
    12-1-2012
  • Epigenetics Implicated in Development of AMD
    ... Like many cancers, stomach cancer is caused by genetic mutations, but also by epigenetic alterations. In their study, Dr. Tan and colleagues used 240 primary tumors and cell lines ...
    11-28-2012
  • NGS & RNA-Seq Form Dynamic Duo
    in blood from patients undergoing breast cancer therapy. [National Cancer Institute] ... the tumor has viruses associated with it. "An example is the analysis of stomach cancers. ...
    7-1-2012
  • Roche CEO Sings China's Praises Noting Country's Interest in...
    non-Hodgkin lymphoma (NHL) indications drove sales; Xeloda for colorectal, stomach, and breast cancer; and Tarceva for non-small-cell lung cancer, which also marked the only ...
    3-7-2012
  • New BRCA1-Associated Breast Cancer Susceptibility Gene Identified
    ... CDH1, and PALB2. A number of the R361Q-positive families also demonstrated other cancer types, including stomach, lung, and lip cancers, neuroblastoma, and lymphoma of the throat. ...
    2-23-2012
  • Avastin Label Changes Reignites Debate: Is OS or PFS the Better...
    or failure, and the development of perforations in the nose, stomach, and intestines. ... Anne Quinn Young recalled how cancer treatment has changed over the past 10 years. ...
    12-12-2011
  • BMS Taps Dako for Companion Diagnostic Development
    Most recently, Dako received FDA approval for HercepTest and HER2 FISH for stomach cancer, making it the first company to get U.S. sanction for a Her2 stomach cancer test. The firm ...
    11-9-2011
  • Animal Studies Provide Early Confirmation of Surprising New Uses...
    ... gene expression data from several human cancer cell lines treated with 164 drugs or ... cluster of cancers, including lung, stomach, and other cancers, pointing to potential ...
    8-18-2011
  • Cancer Genome Researchers Band Together
    oral cavity, ovary, pancreas, prostate, rectum, skin, soft tissues, stomach, and uterus. ... Where groups are studying the same kind of cancer, they have agreed to collaborate. ...
    2-15-2011
  • Houston Biostartups Strong in Innovation
    Brain and lung cancer also are prime candidates for AuroLase Therapy, which is reportedly ... He discovered that phospholipids naturally protect stomach lining from acid damage, but ...
    1-15-2011
  • FDA and EMA Take Steps to Restrict Avastin Use in Breast Cancer
    ... Since the acquisition, Avastin has failed in hormone-refractory prostate cancer and advanced stomach cancer late-stage trials. Roche has managed to add brain and kidney cancers to ...
    12-17-2010
  • FDA Clears Herceptin-Chemotherapy Combo for Metastatic Her2+...
    for the treatment of Her2-positive metastatic stomach or gastroesophageal junction cancer in patients who have not previously received treatment for metastatic disease. ...
    10-21-2010
  • More »

    Journal Articles

  • Technical Feasibility of Robot-Sewn Anastomosis in Robotic Surgery...
    Hoon Hur, June Young Kim, Yong Kwan Cho, Sang-Uk Han
    Journal of Laparoendoscopic& Advanced Surgical Techniquesand Part B, Videoscopy
    stasis in the remnant stomach but conservatively recovered. Conclusions: A robot-sewn anastomosis for reconstruction in robotic surgery for gastric cancer was feasible regardless ...
  • Laparoscopic Transgastric Esophageal Mucosal Resection for High...
    Constantine T. Frantzides, Atul K. Madan, Ronald E. Moore, John G. Zografakis, Mark A. Carlson, Ali Keshavarzian
    Journal of Laparoendoscopic& Advanced Surgical Techniquesand Part B, Videoscopy
    vessels are divided with the harmonic scalpel, to free up the fundus of the stomach. ... neither patient was found to have carcinoma in situ or invasive esophageal cancer. ...
  • Quality of Supportive Care for Patients with Advanced Cancer...
    Jennifer L. Malin, Sean M. O'Neill, Steven M. Asch, Sydney M. Dy, Anne M. Walling, Diana Tisnado, Anna Liza Antonio, Karl A. Lorenz
    Journal of Palliative Medicine
    neck cancer (23% each); 17% had prostate cancer; 13% had colorectal cancer; and the rest (24%) had breast, esophageal, stomach, genitourinary, liver/biliary, or pancreas cancer. ...
  • Specific Targeting of Ep-CAM in Various Carcinomas by Novel Monoclonal...
    Devilakshmi Sithambaram, Shanthi Palanivelu, Krishnakumar Subramanian, Sanjeeb Sahoo, Rama S. Verma
    Hybridoma
    have been deployed to treat cancer using Ep-CAM targeting, including MAb therapy. ... detection of epithelial antigens in breast, colon, stomach, and prostate carcinomas. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll